Effects of Cholesterol-Lowering Therapy on Pressor Hyperreactivity to Stress in Hypercholesterolemic Patients
スポンサーリンク
概要
- 論文の詳細を見る
<B>We previously demonstrated that normotensive patients with hypercholesterolemia showed excessive blood pressure (BP) responses to stress tests. In this study, we examined the effects of cholesterol-lowering therapy on BP in order to confirm that hypercholesterolemia plays a role in the regulation of BP. Fifteen patients with hypercholesterolemia and 24 normal cholesterolemic controls performed mental arithmetic stress (AS) and hand grip (HG) tests. BP was measured during the tests. Serum lipids and lipid peroxides were measured before the AS. Platelet intracellular free calcium concentration ([Ca<SUP>2+</SUP>])<SUB>i</SUB> with and without low density lipoprotein (LDL) stimulation, plasma cGMP and NO<SUB><I>x</I></SUB> were determined immediately before AS and at the end of each test. In hypercholesterolemic patients, the tests were repeated at the end of a 12-week treatment with 10 mg/day of pravastatin, a hepatic hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. In hypercholesterolemic patients, BP responses to both tests were greater than those of the controls. Basal and LDL-stimulated platelet [Ca<SUP>2+</SUP>]<SUB>i</SUB> were higher, and the ratio of plasma cGMP to NO<SUB><I>x</I></SUB> was lower. Serum total cholesterol, LDL cholesterol and lipid peroxides were significantly decreased in association with the pravastatin treatment. Systolic BP to AS and systolic BP/diastolic BP to HG were decreased (<I>p</I> <0.01, <I>p</I> <0.01/<I>p</I> <0.02, respectively). Platelet [Ca<SUP>2+</SUP>]<SUB>i</SUB> with LDL stimulation was decreased (<I>p</I> <0.01). Plasma cGMP was increased (<I>p</I> <0.05), whereas NO<SUB><I>x</I></SUB> was decreased (<I>p</I> <0.05); therefore, the ratio of cGMP to NO<SUB><I>x</I></SUB> was increased (<I>p</I> <0.05). In conclusion, excessive blood pressure responses to stress tests were improved after cholesterol-lowering therapy. This finding suggests that hypercholesterolemia itself is involved in the regulation of BP. (<I>Hypertens Res</I> 2003; 26:273-280)</B>
- 日本高血圧学会の論文
日本高血圧学会 | 論文
- Telmisartan treatment decreases Visceral Fat Accumulation and improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients.
- The Effects of Verapamil SR and Bisoprolol on Reducing the Sympathetic Nervous System's Activity.
- The Role of Renal Dopamine in the Reduction of High Blood Pressure by β1-Selective β-Blocker with Intrinsic Sympathomimetic Activity in Spontaneously Hypertensive Rats
- Effects of Long-Term Antihypertensive Therapy on Physical Fitness of Men with Mild Hypertension.
- Prediction of Progression of Left Ventricular Hypertrophy in Mild Hypertension: 5-Year Observations without Pharmacological Intervention.